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Objective: Spinal cord ischemia (SCI) is a devastating but potentially preventable complication of thoracic endovascular
aortic repair (TEVAR). The purpose of this analysis was to determine what factors predict SCI after TEVAR.
Methods: All TEVAR procedures at a single institution were reviewed for patient characteristics, prior aortic repair history,
aortic centerline of ﬂow analysis, and procedural characteristics. SCI was deﬁned as any lower extremity neurologic deﬁcit
that was not attributable to an intracranial process or peripheral neuropathy. Forty-three patient and procedural variables
were evaluated individually for association with SCI. Those with the strongest relationships to SCI (P < .1) were included
in a multivariable logistic regression model, and a stepwise variable elimination algorithm was bootstrapped to derive a
best subset of predictors from this model.
Results: From 2002 to 2013, 741 patients underwent TEVAR for various indications, and 68 (9.2%) developed SCI
(permanent: n [ 38; 5.1%). Because of the lack of adequate imaging for centerline analysis, 586 patients (any SCI, n [
43; 7.4%) were subsequently analyzed. Patients experiencing SCI after TEVAR were older (SCI, 72 6 11 years; no SCI,
65 6 15 years; P < .0001) and had signiﬁcantly higher rates of multiple cardiovascular risk factors. The stepwise selection
procedure identiﬁed ﬁve variables as the most important predictors of SCI: age (odds ratio [OR] multiplies by 1.3 per
10 years; 95% conﬁdence interval [CI], 0.9-1.8, P[ .06), aortic coverage length (OR multiplies by 1.3 per 5 cm; CI, 1.1-
1.6; P [ .002), chronic obstructive pulmonary disease (OR, 1.9; CI, 0.9-4.1; P [ .1), chronic renal insufﬁciency
(creatinine concentration $ 1.6 mg/dL; OR, 1.9; CI, 0.8-4.2; P [ .1), and hypertension (deﬁned as chart history or
medication; OR, 6.4; CI, 2.6-18; P < .0001). A logistic regression model with just these ﬁve covariates had excellent
discrimination (area under the receiver operating characteristic curve [ .83) and calibration (c2 [ 9.8; P [ .28).
Conclusions: This analysis generated a simple model that reliably predicts SCI after TEVAR. This clinical tool can assist
decision-making about when to proceed with TEVAR, guide discussions about intervention risk, and help determine
when maneuvers to mitigate SCI risk should be implemented. (J Vasc Surg 2014;60:1481-90.)Thoracic endovascular aortic repair (TEVAR) has revo-
lutionized the management of thoracic aortic diseases, with
reduced early morbidity and mortality rates compared with
open operation.1-4 Despite the reduced risk of major
morbidity, spinal cord ischemia (SCI) occurs after TEVAR
in 2% to 15% of patients, which can lead to profound long-
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://dx.doi.org/10.1016/j.jvs.2014.08.103risk of 1-year mortality.5-9 Various proactive and reactive
treatment protocols have been developed in an attempt
to identify strategies to reduce the risk for development
of this potentially devastating complication.9,10 However,
some of these interventions, such as pharmacologic ad-
juncts and spinal drainage, have their own risk of complica-
tions and lead to increased resource utilization, which
argues for a selective approach for initiation of these
therapies.9,11
A number of patient- and procedure-related factors
have been associated with the development of SCI after
TEVAR, including operative indication, urgency, aortic
coverage length, left subclavian artery coverage, adjunctive
procedure use (eg, conduit, embolization, arch or visceral
debranching), age, obesity, blood loss, perioperative hypo-
tension, renal insufﬁciency, presence of unrepaired abdom-
inal aneurysm, and prior history of aortic repair.6,12-15
Whereas these are important for the clinician to consider,
several of the variables are not available in the preoperative
setting, and there are currently no reliable clinical decision-
making tools that can predict SCI after TEVAR.
Given the impact that SCI has on quality of life and
survival after TEVAR, avoidance of this complication is
tantamount to the success of the operation. The purpose
of this study was to develop a predictive model of SCI after
TEVAR, which may help inform decision-making about
whether and when to offer TEVAR to patients at high1481
Fig 1. This image demonstrates the method for obtaining aortic length from the sinotubular junction (red arrow
demonstrates the left coronary artery, white arrows are the region of the proximal stent boundary) to the aortic
bifurcation. This patient’s total aortic length was 525 mm along the centerline. A measurement of the total stent
coverage, which is equivalent to the total aortic coverage length, was determined by measurement of the centerline
distance from the most proximal stent boundary to the most distal stent boundary. The percentage of aortic coverage
was derived by dividing the total aortic coverage length by total aortic length  100. Additional measurements were
taken from the most distal stent boundary to the top of the celiac and superior mesenteric artery origins as well as to the
aortic bifurcation. The total number of aortic zones that were covered was tabulated and included total and partial zone
coverages (eg, if the distal stent boundary extended only partially into zone 5, this was tabulated as a covered zone).
JOURNAL OF VASCULAR SURGERY
1482 Scali et al December 2014risk for SCI and can guide the use of adjunctive maneuvers
to mitigate SCI risk in the perioperative setting.METHODS
The University of Florida Institutional Review Board
(FWA00005790) approved this study. A waiver of
informed consent was granted because all collected data
pre-existed in medical records and no study-related inter-
ventions or subject contact occurred. Therefore, the rights
and welfare of these subjects were not adversely affected.
Patient cohort and deﬁnitions. A retrospective anal-
ysis was performed on a prospectively maintained endovas-
cular aortic database, and all TEVAR patients from 2002 to
2013 were reviewed. Demographics, comorbidities, history
of previous aortic surgery, and procedural details were
determined by review of the database or electronic medical
record. Comorbidities (see Supplementary Table I, online
only, for deﬁnitions), coverage zones, and proceduraladjuncts were deﬁned and recorded by Society for Vascular
Surgery reporting standards.16
Aortic centerline analysis. The ﬁrst postoperative
computed tomographic angiogram for each patient was
analyzed to obtain speciﬁc anatomic covariates. There
were 586 patients with adequate imaging to create a
centerline with use of an Aquarius workstation (TeraRecon,
Santa Rosa, Calif), and they constitute the primary study
population in whom subsequent predictive modeling was
performed. Multiple measurements were made, including
total aortic length (deﬁned as the distance from the sino-
tubular junction to the aortic bifurcation) as well as the
length and percentage of covered aorta (proximal stent
boundary to most distal stent boundary). Additional vari-
ables that were recorded as well as a detailed description
of the centerline measurement methodology are high-
lighted in Fig 1. Two independent observers performed
the measurements by the described methods, and inter-
observer agreement was excellent [Spearman correlation,
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(6standard deviation ¼ 0.37; P ¼ .54)].
Clinical practice. SCI has been consistently7,12,14,17
deﬁned at our institution as any new lower extremity mo-
tor or sensory deﬁcit that is not explained by any intra-
cranial process or peripheral nerve dysfunction (eg, epidural
hematoma, stroke, peripheral neuropathy, or neurapraxia)
and may range from frank paralysis to mild paraparesis.
Patients were offered preoperative spinal drainage at the
discretion of the operating surgeon. In general, elective
patients with an anticipated aortic coverage length
$150 mm were given preoperative spinal drains, and pa-
tients treated emergently had spinal drains placed selec-
tively once stabilized.
If SCI developed, the mean arterial pressure was typi-
cally raised to a goal of $90 mm Hg, which was achieved
by volume resuscitation and vasoactive agents as needed,
depending on the clinical scenario. The goal cerebrospinal
ﬂuid pressure was kept at 10 mm Hg, and if symptoms per-
sisted, this would be lowered to 5 mm Hg to promote
efﬂux of spinal ﬂuid. Patients routinely had cerebrospinal
ﬂuid drained for 72 hours after the onset of symptoms,
and those who did not experience complete resolution of
their symptoms postoperatively were classiﬁed as having
permanent SCI. Adjunctive maneuvers such as motor
evoked potentials and epidural cooling were not employed.
In addition, pharmacologic agents such as corticosteroids
and naloxone were not routinely used during the study in-
terval. Finally, neurologic consultation with or without
conﬁrmatory spinal magnetic resonance imaging was ob-
tained only in equivocal cases. No signiﬁcant changes
occurred to this protocol during the study interval.
Development of SCI prediction model. There was
complete demographic, periprocedural, and aortic center-
line measurement data for 79% (n ¼ 586) of patients, 43
of whom had SCI. Forty-three patient and procedural
variables were evaluated separately for association with SCI.
Those with the strongest relationships to SCI (P < .1) were
included in a full multivariable logistic regression model.
This model included age, stent length, aortic bifurcation to
distal TEVAR stent length, distal landing zone designation,
preoperative indication, American Society of Anesthesiol-
ogists status, chronic obstructive pulmonary disease
(COPD), chronic renal insufﬁciency (CRI; creatinine
concentration $ 1.6 mg/dL), smoking, hypertension,
hyperlipidemia, peripheral vascular occlusive disease, cere-
brovascular occlusive disease, ﬂuoroscopy time, contrast
volume exposure, and procedure time (incision to dres-
sing). Subsequently, ﬂuoroscopy time, contrast volume,
and procedure time were removed because they are not
available in the preoperative setting.
To derive the best subset of predictors from the full
preoperative model, a stepwise elimination algorithm based
on the Akaike information criterion (the stepAIC function
in the R package MASS) was used. Because stepwise proce-
dures are known to be somewhat unstable and vulnerable
to the inﬂuence of extreme observations, the stepwise pro-
cedure was bootstrapped 100 times, and the number oftimes each variable in the full model was selected for inclu-
sion in the reduced model was recorded. This process iden-
tiﬁed hypertension, age, aortic coverage length, CRI, and
COPD as the most important and consistent predictors
of SCI. A model with just these ﬁve covariates yielded
the following equation: probability of SCI ¼ exp(X)/
[1 þ exp(X)], where X ¼ A þ B*age þ C*coverage
length þ D (if “yes” hypertension) þ E (if “yes”
COPD) þ F (if “yes” preoperative creatinine concentration
$ 1.6 mg/dL), with A ¼ 7.45, B ¼ 0.03, C ¼ 0.006,
D ¼ 1.86, E ¼ 0.64, and F ¼ 0.64. To estimate the perfor-
mance of the model on new data, the model was applied to
1000 bootstrapped samples from the original data set, and
the mean area under the receiver operating characteristic
curve (AUC), with 95% conﬁdence intervals (CIs), was
determined.
RESULTS
Patient characteristics. Between January 2002 and
June 2013, 741 patients underwent TEVAR for multiple
indications, and 68 (9.2%) experienced postoperative SCI
(permanent, n ¼ 38; 5.1%). On univariate testing, signiﬁ-
cant differences in age and multiple comorbidities were
found between the two patient cohorts. The data regarding
patient demographics, comorbidities, and history of prior
aortic repair are highlighted in Table I. Details regarding
the indication-speciﬁc SCI rates after TEVAR are demon-
strated in Fig 2.
The indications, procedural urgency, spinal drain use,
and other intraoperative features of the TEVAR patients
are depicted in Table II. Rate of preoperative spinal drain
use did not differ (P ¼ 1); however, patients documented
to have experienced postoperative SCI were signiﬁcantly
more likely to have an American Society of Anesthesiolo-
gists class 4 designation (P ¼ .05) and to have longer ﬂuo-
roscopy (P ¼ .04) and procedure times (P ¼ .05). Details
of the anatomic measurement variables that were captured
in the centerline analysis are displayed in Table III. Patients
undergoing TEVAR for a thoracoabdominal aneurysm
indication had the greatest overall coverage length for the
entire cohort [mean 6 standard deviation, 272 6
104 mm; median [IQR] (range), 268 [183-326] (107-
508)], whereas traumatic transection cases had the shortest
absolute coverage length [100 6 32; 93 [84-106] (48-
216)] (Supplementary Table II, online only).
Outcomes. The overall 30-day mortality was 6% (n ¼
4) and 4% (n ¼ 25) in patients with and without SCI (P ¼
.3), respectively. Mean length of stay was signiﬁcantly
greater in patients with SCI (median, 13 [IQR, 8-22] days
vs no SCI, 5 [3-9] days; P < .0001). Additional details of
other complications that occurred in the two groups are
listed in Table IV. Of note, SCI patients were signiﬁcantly
more likely to have a postoperative pulmonary (P ¼ .0004)
or renal complication (P ¼ .005). The all-cause mortality,
deﬁned as any death that occurred during the follow-up
interval, was signiﬁcantly different between patients with
or without SCI after TEVAR (log-rank, P < .001;
Supplementary Fig, online only).
Fig 2. This graph demonstrates the indications for thoracic
endovascular aortic repair (TEVAR) in our data set and the
prevalence of any form of spinal cord ischemia (SCI) in each group
at the top of each bar. The most common indication was thoracic
aneurysm, with an overall SCI rate of 8.8%. The highest rate of SCI
was within the thoracoabdominal aortic aneurysm (TAAA) group
and was 15.4%. cTBAD, Complex type B aortic dissection; PAU,
penetrating aortic ulcer; TAT, traumatic aortic transection.
Table I. Patient demographics and comorbidities of all
TEVAR patients
Feature
No SCI
(n ¼ 673)
SCI
(n ¼ 68)
P
value
Age, years 65 6 15 72 6 11 <.0001
Female 211 (32) 24 (35) .6
Body mass index 27.6 6 5.6 27.3 6 6.4 .7
Hypertension 259 (39) 61 (90) <.0001
Dyslipidemia 124 (18) 31 (46) <.0001
COPD 58 (9) 21 (31) <.0001
Smoking (any history) 136 (20) 28 (41) .0001
Renal insufﬁciency
(creatinine > 1.6 mg/dL)
55 (8) 22 (32) <.0001
Cerebrovascular disease 20 (3.) 11 (16) <.0001
Peripheral arterial disease 24 (4) 7 (10) .02
Coronary artery disease 87 (13) 13 (19) .2
Diabetes mellitus 44 (7) 6 (9) .6
Arrhythmia 26 (4) 5 (7) .3
Prior aortic repair 136 (20) 18 (27) .3
COPD, Chronic obstructive pulmonary disease; SCI, spinal cord ischemia;
TEVAR, thoracic endovascular aortic repair.
Continuous data are presented as mean6 standard deviation and categorical
data as number (%).
Table II. Procedural characteristics of all patients
undergoing thoracic endovascular aortic repair (TEVAR)
Feature
No SCI
(n ¼ 673)
SCI
(n ¼ 68)
P
value
Indication
Thoracic aneurysm 279 (42) 27 (40)
Acute dissection 87 (13) 14 (21)
Chronic type B
dissection
93 (14) 9 (13)
Othera 209 (31) 18 (27) .4
Urgency
Urgent/symptomatic 128 (19) 16 (24)
Emergent/ruptured 117 (17) 15 (22) .3
ASA status
Class 3 145 (22) 7 (10)
Class 4 391 (58) 43 (63) .05
Pre-TEVAR implant
spinal drain
290 (43) 27 (40) 1
Postoperative spinal
drain
16 (2) 38 (56) <.0001
Anesthesia
General 472 (70) 56 (82)
Regional 200 (30) 13 (18) .1
Device
Cook TX2 263 (40) 33 (49)
Gore TAG 241 (36) 25 (37)
Fenestrated graft 38 (6) 7 (10)
Medtronic Talent/
Valiant
85 (12) 1 (2)
Bolton Relay 25 (4) 1 (2)
Aortic cuff 13 (2) 0 .3
Access vessel open or
endo conduit
139 (21) 20 (29) .1
Any intraoperative
adjunct
266 (40) 27 (40) 1
Carotid-subclavian bypass
Postoperative 7 (1) 3 (4)
Intraoperative with
TEVAR
41 (6) 2 (3)
Preoperative 45 (7) 6 (9) .07
Procedural details
Fluoroscopy time,
minutes
18 (12-29) 27 (16-44) .04
Contrast exposure,
mL
120 (87-160) 140 (99-196) .09
Estimated blood
loss, mL
250 (200-300) 250 (200-313) .5
Procedure time,
hours
1.7 (1.2-2.8) 2.0 (1.5-3.2) .05
ASA, American Society of Anesthesiologists; SCI, spinal cord ischemia.
Continuous data are presented asmedian (interquartile range) and categorical
data as number (%).
aIncludes penetrating ulcer, traumatic transection, thoracoabdominal
aneurysm, pseudoaneurysm, mycotic aneurysm with visceral debranching,
and Kommerell diverticulum.
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were excluded from the analysis because they did not
receive follow-up CT scans and thus their percentage
coverage data were missing. A comparison of these patients
to the 586 patients included in the development of the
model shows that the excluded patients had a signiﬁcantlyhigher rate of SCI, were signiﬁcantly older, had higher
rates of multiple comorbidities, presented more urgently or
emergently, and were more likely to suffer multiple post-
operative complications (Table V).
Of the 43 patient and procedural variables that were
evaluated separately for association with SCI, 13 with
the strongest relationships to SCI (P < .1) were included
in a full multivariable logistic regression model. Of these
Table III. Anatomic categorization and measurements
of TEVAR patientsa
Feature
No SCI
(n ¼ 673)
SCI
(n ¼ 68)
P
value
Proximal landing zone
Zones 0-2 316 (47) 31 (46)
Zones 3-5 353 (53) 37 (54) .6
Distal landing zone
Zone 4 267 (40) 25 (37)
Zone 5 308 (46) 26 (39)
Zones 6-11 96 (14) 16 (24) .1
No. of zones covered 3.5 6 1.5 3.8 6 1.8 .3
No. of stents implanted 2.0 6 1.1 2.4 6 0.9 <.0001
Total aortic length, mm 541 6 62 547 6 54
Total stented length, mm 213 6 88 272 6 65 <.0001
% Aortic coverage 39 6 14 50 6 10 <.0001
Distal stent to aortic
bifurcation, mm
202 6 85 157 6 54 <.0001
Celiac to aortic
bifurcation, mm
143 6 26 142 6 26 .6
SMA to aortic
bifurcation, mm
125 6 24 123 6 24 .6
SCI, Spinal cord ischemia; SMA, superior mesenteric artery; TEVAR,
thoracic endovascular aortic repair.
Continuous data are presented as mean 6 standard deviation and cate-
gorical data as number (%).
aBased on available computed tomography (CT) imaging; 586 patients had
complete imaging. However, additional patients had missing CT data or
non-contrast-enhanced CT scans because of chronic renal insufﬁciency, so
centerline reconstruction was not always possible.
Table IV. Outcomes after TEVAR in all patients with or
without spinal cord ischemia (SCI)
Feature
No SCI
(n ¼ 673)
SCI
(n ¼ 68) P valuea
Thirty-day mortality 25 (4) 4 (6) .3
Length of stay 5 (3-9) 13 (8-22) <.0001
Complications
Pulmonary 51 (8) 15 (22) .0004
Renal 35 (5) 10 (15) .005
Bleeding 25 (4) 4 (6) .3
Stroke 21 (3) 4 (6) .3
Gastrointestinal 20 (3) 3 (4) .5
Cardiac 20 (3) 4 (6) .3
TEVAR, Thoracic endovascular aortic repair.
Continuous data are presented as median (interquartile range) and cate-
gorical data as number (%).
aP values were generated by c2 or Fisher exact test when appropriate.
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ped 100 times to protect against spurious associations,
identiﬁed ﬁve as having the most predictive power
(Table VI). Prior analysis demonstrated that age and
aortic coverage length had roughly linear relationships
with the probability for development of SCI, so these as-
sociations were modeled as linear throughout the model-
building process. These associations are demonstrated in
Fig 3.
In further discriminating the nature of hypertension as
a predictor of SCI, a weak association with chronic
(>30 days) preoperative use of a-blocking agents (eg,doxazosin, terazosin, prazosin, clonidine, methyldopa,
guanethidine) was noted (P ¼ .07). No other medication
class or total number of antihypertensive medications
(P ¼ .4) was found to be associated with development of
SCI.
Selected predictors of any SCI were age (odds ratio
[OR] multiplies 1.3 per 10 years; 95% CI, 0.9-1.8; P ¼
.06), aortic coverage length (OR multiplies 1.3 per 5 cm;
CI, 1.1-1.6; P ¼ .002), COPD (OR, 1.9; CI, 0.9-4.1;
P ¼ .1), CRI (OR, 1.9; CI, 0.8-4.2; P ¼ .1), and hyperten-
sion (OR, 6.4; CI, 2.6-18; P < .0001). A model with only
these covariates had excellent discrimination (AUC ¼ .83)
and calibration (c2 ¼ 9.8; P ¼ .28; Fig 4). In 1000 boot-
strapped iterations, the model had mean AUC of .84 (95%
CI, 0.79-0.91).
The additive impact of the different predictors on the
risk for development of SCI after TEVAR is further
demonstrated in Fig 5. For example, a 65-year-old patient
with no history of hypertension who undergoes TEVAR
with an aortic coverage length of 10 cm has a predicted
risk of SCI that is #1%; however, an 80-year-old patient
with hypertension and planned 30 cm of aortic coverage
can have a risk for SCI that approaches 20%.
DISCUSSION
Multiple reports have documented various predictors
of SCI after TEVAR.14,15,18-22 However, the current anal-
ysis is the ﬁrst to identify independent factors that can be
used preoperatively to derive the predicted risk of SCI after
TEVAR. Preoperative variables that were most strongly
associated with SCI included advanced age, hypertension,
COPD, CRI, and aortic coverage length. This predictive
model had high ﬁdelity and generated a simple clinical de-
cision tool based on readily available factors that can be
used to facilitate clinical decision-making and inform pa-
tient counseling about the risk of TEVAR.
The less invasive nature of TEVAR has led to repeated
demonstration that it has lower perioperative morbidity
and mortality compared with open operation,1,2,4,23 which
has resulted in an increasing number of patients deemed
eligible for repair without strong evidence of longer term
beneﬁt.24,25 Despite the perioperative advantage of
TEVAR compared with open aortic repair, SCI remains a
devastating complication that has profound inﬂuence on
long-term outcome. In our experience, patients who
develop permanent SCI after TEVAR have a mean postop-
erative survival of 37 6 5 months compared with 72 6
4 months in patients without SCI (P < .0006).7 Therefore,
identiﬁcation of which patients are most vulnerable and
prevention of this complication are crucial to achieving suc-
cessful outcome after TEVAR.
There are multiple reported risk factors for development
of SCI after TEVAR that are based on patient demographics,
comorbidities, presentation, anatomic considerations of the
repair, and postoperative events.5,6,12,15,26 The most
frequently identiﬁed risk factor is length of aortic coverage.
A variety of thoracic aortic diseases may involve large seg-
ments of the aorta, such as the case with thoracoabdominal
Table V. Comparison of included and excluded patients used in development of the preoperative prediction of spinal
cord ischemia (SCI) after TEVAR model
Feature In model (n ¼ 586; 79%) Not in model (n ¼ 155; 21%) P value
Any SCI 43 (7) 25 (16) .001
Age, years 65 6 15 68 6 14
Female 184 (32) 53 (34) .02
BMI 28 6 6 27 6 5 .6
Comorbidities
Hypertension 243 (42) 77 (50) .08
Hyperlipidemia 118 (20) 37 (24) .4
Coronary artery disease 72 (12) 28 (18) .08
CRI (creatinine > 1.6 mg/dL) 51 (9) 26 (17) .005
Diabetes 40 (7) 10 (7) 1
Congestive heart failure 22 (4) 8 (5) .6
Peripheral arterial disease 24 (4) 7 (5) .9
Cerebrovascular disease 18 (3) 13 (8) .007
Arrhythmia 24 (4) 7 (5) .9
Indication
Thoracic aneurysm 245 (42) 61 (40)
Acute dissection 76 (13) 25 (16)
Chronic type B dissection 85 (15) 17 (11)
Othera 177 (30) 50 (33) .5
Urgency
Elective 379 (65) 84 (55)
Urgent/emergent 206 (35) 70 (45) .007
Anesthesia type
General 403 (69) 125 (81)
Regional 179 (30) 30 (19)
Local 3 (1) 0 (0) .02
Procedure-related details
Proximal landing zone 0-2b 258 (44) 89 (57) .02
Distal landing zone 4 157 (27) 135 (89) <.0001
Any adjunct use 232 (40) 61 (39) 1
Use of open or endo conduit 126 (22) 33 (22) 1
Procedure time, hours 2.2 6 1.6 2.5 6 2.0 .6
Fluoroscopy time, minutes 18 (0-165) 21 (13-32) .6
Contrast use, mL 128 6 64 121 6 70 .6
Estimated blood loss, mL 250 (200-300) 250 (150-338) .2
Outcomesc
In-hospital and/or 30-day death 7 (1) 22 (14) <.0001
Any complication 192 (33) 76 (49) .0002
Stroke 12 (2) 13 (8) .0005
Renal complication 26 (4) 19 (12) .0009
Pulmonary complication 42 (7) 24 (16) .002
BMI, Body mass index; CRI, chronic renal insufﬁciency; TEVAR, thoracic endovascular aortic repair.
Continuous data are presented as mean 6 standard deviation or median (interquartile range), and categorical data are presented as number (%).
aOther includes penetrating ulcer, traumatic transection, thoracoabdominal aneurysm, pseudoaneurysm, mycotic aneurysm with visceral debranching, and
Kommerell diverticulum.
bWhen individual zone analysis was performed, no signiﬁcant association with SCI was noted.
cAll other complication categories had no signiﬁcant differences.
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experience, patients undergoing TEVAR for these indica-
tions had the highest overall rates of SCI (Fig 2). Impor-
tantly, our study demonstrated that aortic coverage
length was linearly correlated with the risk of SCI, so
choice of any speciﬁc value would be arbitrary. The reason
for the increased risk of SCI as a function of aortic
coverage length is thought to be due to the segmental
blood supply of the spinal cord and endograft coverage
of important radicular arteries as well as the putative loca-
tion of the artery of Adamkiewicz in the distal thoracic
aorta.27,28An interesting predictor of SCI after TEVAR in this
analysis is a preoperative diagnosis of hypertension.
Although it is not often described in the TEVAR literature,
some insight about the potential physiologic reason for this
association may be gained by review of the open thora-
coabdominal aortic aneurysm (TAAA) repair literature. A
variety of hemodynamic factors have been reported to be
associated with elevated risk of SCI in open TAAA repair,
including arterial hypotension, decreased cardiac index,
and reduced oxygen-carrying capacity from anemia.29,30
One mechanistic explanation as to why hypertension was
such an important predictor in our series may be related
Table VI. Results of stepwise elimination algorithma
Variable
No. of times chosen
as important predictor
Aortic coverage length 96
Hypertension 93
Age 67
COPD 66
CRI (creatinine > 1.6 mg/dL) 49
ASA class 4 44
Smoking (any history) 38
Indication 33
Cerebrovascular occlusive disease 30
Distal landing zone beyond zone 4 29
ASA, American Society of Anesthesiologists; COPD, chronic obstructive
pulmonary disease; CRI, chronic renal insufﬁciency.
aAfter initial 100 bootstrapped samples were analyzed to generate this list of
predictors, the best set of predictors were then chosen and 1000 boot-
strapped samples were tested to determine model reliability.
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Spinal cord perfusion pressure is dictated by the difference
in mean systemic arterial pressure and cerebrospinal ﬂuid
pressure. It is possible that patients with pre-existing hyper-
tension require a higher basal mean arterial pressure to
maintain cord perfusion after TEVAR, similar to how
certain patient groups with renal artery stenosis experi-
encing postoperative hypotension are vulnerable to acute
kidney injury.31
Another important variable that was identiﬁed in this
analysis is age. Other reports have corroborated this
ﬁnding14,32; however, there may be several explanations
for the associated risk of SCI with increasing age. From a
statistical standpoint, age is a better candidate predictor
than any single comorbidity because it is a continuous var-
iable that all patients possess, which allows any two patients
to be directly compared. The presumption that older pa-
tients have higher likelihood of multiple comorbidities
that increase risk of SCI would not entirely explain the
age correlation to SCI because the effect of age should
disappear when all the different covariates were considered
in the development of the model. The more probable
explanation is that older patients are likely to have many
unknown biologic vulnerabilities that cannot be accounted
for in the prediction model. We speculate that these vulner-
abilities may be related to subtle postoperative derange-
ment in cardiac performance indices, underappreciated
comorbidity severity, or unmeasured local and systemic
changes in spinal cord metabolism.
Finally, our model included CRI as well as COPD.
Renal insufﬁciency has been reported to be signiﬁcantly
associated with SCI in both TEVAR6,26 and open TAAA
series.32,33 A more precise method for deﬁning CRI would
have been analysis of preoperative estimated glomerular
ﬁltration rate (eGFR) instead of using a creatinine concen-
tration $ 1.6 mg/dL. However, we excluded eGFR as a
candidate predictor in our model because this data point
was missing for 28% of subjects. Notably, SCI rates among
patients for whom eGFR was available show a highlysigniﬁcant and approximately linear relationship. Unad-
justed for any covariates, the odds of SCI are estimated
to multiply by 0.98 for each unit increase in eGFR (95%
CI, 0.97-0.99; P < .001). The mechanism for this is poorly
understood, but some have postulated that CRI is a marker
for severe systemic peripheral atherosclerotic disease.
Accordingly, these patients may have diseased radicular col-
laterals making the spinal cord more susceptible to hemo-
dynamic perturbations after TEVAR. Similarly, although
not previously described in TEVAR subjects, COPD pa-
tients may have compromised oxygen kinetics34 that may
lead to the increased risk of axonal injury during times of
neuronal ischemia.
Our current clinical practice has evolved as a result of
this analysis and appreciation of the increasing body of
literature on the topic of SCI after TEVAR. We currently
employ a liberal spinal drainage protocol and aggressively
revascularize the left subclavian artery in elective cases in
which coverage of the vessel origin is required to achieve
an adequate proximal landing zone; however, our blood
pressure management has been modiﬁed. Examples of
this include more routine use of permissive hypertension
(goal mean arterial pressure > 90 mm Hg in all patients),
and many patients now have their a-blocking or
angiotensin-converting enzyme inhibitor medications
withheld perioperatively. This shift in clinical practice is
supported by the report from Bobadilla et al10 and makes
our management more proactive than reactive to the devel-
opment of SCI after TEVAR. In addition, although we
have a well-described and previously published SCI treat-
ment protocol,7,12,14,17 we are developing a “spinal cord
ischemia bundle” similar to what has been done for
ventilator-associated pneumonia in surgical intensive care
units.35 This effort will, it is hoped, pre-identify the most
vulnerable patients and improve care processes. Last, the
risk model is used in our preoperative decision-making in
trying to decide which patients should receive TEVAR as
well as to improve discussions about the risks and beneﬁts
of repair.
There are several limitations to this study, including the
retrospective, single-center experience, which introduces
inherent selection bias to the analysis. Although we offer
a novel description of a preoperative prediction clinical
decision-making tool for SCI after TEVAR, validation in
a multicenter trial or registry data set is required before
broader application in routine clinical practice. Intercostal
and hypogastric artery patency was not speciﬁcally captured
in the data set and may have allowed better reﬁnement of
the predictive model. Despite this shortcoming, our model
had an AUC of .83, which is excellent for a biologic predic-
tion model.
Hypertension was not anticipated to be such a strong
independent predictor of the development of SCI after
TEVAR, so mechanistic insight about this covariate is
limited. The retrospective nature of the study restricts the
ability to accurately grade hypertension severity and dura-
tion. A chart history or chronic (>30 day) preoperative
use of antihypertensive medications was used to deﬁne
Fig 3. These graphs demonstrate the association of age (A) and coverage length (B) to spinal cord ischemia (SCI).
There is essentially a linear relationship with these two variables to the occurrence of SCI.
Fig 4. Left, The model developed from our multivariable analysis. The sample case is a 65-year-old patient with 30 cm
of coverage length and a history of hypertension. The probability of spinal cord ischemia (SCI) in this patient is 6.9%
based on those parameters. Right, The receiver operating curve, which demonstrates an area under the curve (AUC) of
0.84 from the bootstrapped iterative sampling. CI, Conﬁdence interval.
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not available. Importantly, we do not have detailed intrao-
perative or postoperative hemodynamic data to help deter-
mine whether and when true or relative hypotension
occurred, making it difﬁcult to determine what role this
played in the pathophysiologic process of each patient’s
SCI. However, our sense is that relative hypotensive events
(compared with the patient’s preoperative outpatient base-
line blood pressure) may have precipitated SCI in some
cases, especially because hypertension was a signiﬁcant in-
dependent predictor in the model. In addition, this analysis
relied on several broad deﬁnitions to document other pa-
tient comorbidities, and the imprecise severity grading
and resulting impact on the analysis are not readily known.
Further, SCI was deﬁned broadly, which increased
overall sensitivity for its detection and could lower speci-
ﬁcity. This may have introduced unmeasured bias or con-
founding into the models. Despite having a relativelylarge number of patients in the analysis, the event rate for
SCI is modest, which limits the number of predictors
that can be reasonably identiﬁed without overﬁtting statis-
tical models. This is particularly important because there
are known differential risks with various patient presenta-
tions (eg, urgent/emergent presentations, dissection-
related disease). We excluded 21% of the patients in the
original data set, which could have allowed more robust
modeling; however, missing CT imaging did not allow
this analysis. Notwithstanding removal of these subjects,
four of the ﬁve variables we identiﬁed as predictors of
SCI for patients included in the analysis are also associated
with SCI for the group of excluded patients, so we believe
the likelihood that the exclusions biased our results is small.
However, any association between aortic coverage length
and SCI in the group of excluded patients, along with
the effect it might have had on our results, cannot be
determined.
Fig 5. This ﬁgure demonstrates the estimated probability of spinal
cord ischemia (SCI) related to each of the demonstrated combinations
of risk factors. A 65-year-old patient with a short coverage length of
100 mm and no history of hypertension (HTN) would have a preop-
erative predicted rate of post-thoracic endovascular aortic repair
(TEVAR) SCI of <1%, whereas an 80-year-old patient with a long
coverage length of 300mm and a history of hypertension would have a
predicted SCI rate that can approach 20%. O/E, Observed/expected.
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This study demonstrated that hypertension, advanced
age, COPD, CRI, and longer aortic coverage lengths are
highly predictive of SCI after TEVAR. On the basis of
these data, we have modiﬁed our existing SCI management
protocols by liberalizing our postoperative blood pressure
parameters and use these data in our patient discussions
and decision algorithm for whether and when to proceed
with aortic repair. Validation of this predictive model is
needed before broader clinical application should occur.
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Supplementary Table I (online only). Comorbidity deﬁnitions
Comorbidity Deﬁnition
Arrhythmia Requiring medical intervention and/or escalation in monitoring/care level
Coronary artery disease Any history of MI, angina, prior coronary intervention, or ECG changes consistent with prior MI
Cerebrovascular disease History of TIA, stroke, and/or prior carotid endarterectomy/stent
Congestive heart failure Chart history, New York Heart Association II or greater or on preoperative evaluation, EF < 40%
Chronic obstructive
pulmonary disease
Chart history or preoperative pulmonary function testing consistent with the diagnosis
Diabetes mellitus Chart history, insulin or noninsulin requiring
Chronic renal insufﬁciency Creatinine > 1.6 mg/dL and/or dialysis dependence
Hypertension Chart history, taking antihypertensive medications, or preoperative blood pressure $ 140/90 mm Hg
Dyslipidemia Chart history, taking cholesterol-lowering medications
Peripheral arterial disease ABI < 0.9, chart history, prior peripheral endovascular intervention, or open infrainguinal reconstruction
ABI, Ankle-brachial index; ECG, electrocardiogram; EF, ejection fraction; MI, myocardial infarction; TIA, transient ischemic attack.
Supplementary Table II (online only). Aortic coverage
length data for various thoracic endovascular aortic repair
(TEVAR) indicationsa
Indication
Aortic coverage length, mm
Mean 6 SD Median [IQR] (range)
Acute dissection
(n ¼ 75)
245 6 74 253 [186-285] (90-451)
Chronic type B
dissection (n ¼ 86)
238 6 70 249 [183-285] (102-457)
Thoracic aneurysm
(n ¼ 245)
238 6 81 237 [183-283] (56-494)
Penetrating ulcer
(n ¼ 62)
160 6 61 141 [122-186] (76-343)
Traumatic transection
(n ¼ 37)
100 6 32 93 [84-106] (48-216)
Thoracoabdominal
aneurysm (n ¼ 31)
272 6 104 268 [183-326] (107-508)
Postsurgical
pseudoaneurysm
(n ¼ 22)
178 6 79 181 [119-209] (34-376)
Other (n ¼ 26)b 134 6 62 125 [109-147] (66-386)
IQR, Interquartile range; SD, standard deviation.
aN ¼ 586 patients with available computed tomography imaging that was
adequate for aortic centerline three-dimensional reconstruction.
bOther includes Kommerell diverticulum, atheromatous disease, and
mycotic indications.
Supplementary Fig (online only). This ﬁgure demonstrates the
all-cause mortality after thoracic endovascular aortic repair
(TEVAR) for patients with and without any degree of spinal cord
ischemia (SCI) (log-rank, P < .001). The standard error of the
mean is < 10% for all displayed intervals.
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